GlassScriptPhysician profile
Tiffany Gebel
NPI 1942460712
$823.00
in general payments reported to CMS, 2019-2025
16 companies · $17.21 in 2025
The $17.21 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.64 · 2020: $71.48 · 2021: $75.45 · 2022: $235 · 2023: $290 · 2024: $34.86 · 2025: $17.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $342.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $341.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $250.00 | 2023 | Xeomin |
| Amgen INC. | $198.99 | 2022 | |
| Smith+Nephew, INC. | $69.18 | 2019-2021 | |
| Medtronic Vascular, INC. | $67.66 | 2019 | |
| Kci USA, INC. | $37.40 | 2020-2021 | |
| Hologic Sales and Service, LLC | $23.78 | 2022 | |
| Evofem Biosciences, INC. | $23.45 | 2021 | |
| Sumitomo Pharma America, INC. | $23.21 | 2023 | Myfembree |
| Abbvie INC. | $20.79 | 2024 | |
| Boston Scientific Corporation | $18.44 | 2020 | |
| Novo Nordisk INC | $17.21 | 2025 | Wegovy |
| Coopersurgical, INC. | $16.35 | 2023 | Endosee |
| Merck Sharp & Dohme LLC | $16.24 | 2020 | |
| Aesculap, INC. | $14.20 | 2019 | |
| Exeltis, USA INC. | $14.07 | 2024 | Slynd |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $12.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiffany Gebel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.